Edwards Lifesciences Return on Sales Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 113.08  1.05  0.94%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Return on Sales of Edwards Lifesciences Corporation with missing and latest data points interpolated. Return on Sales is a ratio to evaluate a company's operational efficiency, calculated by dividing Earning Before Interest and Taxes EBIT by Revenues. ROS is often a component of DuPont return on equity.
Return on Sales  10 Years Trend  
Increasing
Slightly volatile
 Return on Sales 
      Timeline 

Edwards Lifesciences Return on Sales Over Time

2015-12-31  0.26 
2016-12-31  0.26 
2017-12-31  0.27 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  0.22
Geometric Mean  0.18
Coefficient Of Variation  51.5
Mean Deviation  0.074829
Median  0.23
Standard Deviation  0.11
Sample Variance  0.012798
Range  0.48
R Value  0.68
Mean Square Error  0.00751
R Squared  0.47
Significance  0.014353
Slope  0.021432
Total Sum of Squares  0.14

Currently Trending

V   
 NYQ 
Purchased over 20 shares of
few hours ago ago
Traded for 107.02
GOOG   
 NMS 
Purchased few shares of
few hours ago ago
Traded for 984.45
VMW   
 NYQ 
Purchased over 20 shares of
few hours ago ago
Traded for 117.4